Results 221 to 230 of about 169,351 (334)

The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long‐Term Administration of Nucleos(t)ide Analogs

Hepatology Research, EarlyView.
The risk of HCC persists long after NUC initiation. In noncirrhotic patients, the risk remains stable more than 10 years after NUC treatment initiation. ABSTRACT Background and Aim Nucleos(t)ide analogs (NUCs) are used in the treatment of chronic hepatitis B (CHB).
Kazuhiro Murai, Hayato Hikita, Ryoko Yamada, Yuki Nishimura, Masanori Miyazaki, Hisashi Ishida, Atsushi Hosui, Ryotaro Sakamori, Nobuyuki Tatsumi, Kazuyoshi Ohkawa, Yoshinori Doi, Takatoshi Nawa, Satoshi Egawa, Yuichi Yoshida, Yasutoshi Nozaki, Kazuho Imanaka, Masanori Nakahara, Mitsuru Sakakibara, Takayuki Yakushijin, Hiroyuki Ogawa, Takeo Usui, Kengo Matsumoto, Tsugiko Oze, Shinji Kuriki, Emi Sometani, Jihyun Sung, Akiyoshi Shimoda, Satoshi Shigeno, Kazuki Maesaka, Kumiko Shirai, Akira Doi, Yuki Tahata, Yoshinobu Saito, Takahiro Kodama, Tomohide Tatsumi, Tomomi Yamada, Tetsuo Takehara   +36 more
wiley   +1 more source

Genetic association analysis between LDL-c lowering drugs and portal hypertension using Mendelian randomization analysis. [PDF]

Sci Rep
Xiao QA, Li XL, Qin L, Zhang XL.
europepmc   +1 more source

Lessons from implementation of a nephrology key performance indicator programme

Internal Medicine Journal, EarlyView.
Abstract Background We review the impact of a nephrology key performance indicator (KPI) program implemented over a ten‐year period in Victoria, Australia. The program enabled transparent comparison of performance across nephrology units, however improvement against performance targets was not consistent and better understanding of KPIs is required to ...
Adam G. Steinberg, Peter F. Mount, Maree Branagan, Matthew A. Roberts, Nigel D. Toussaint   +4 more
wiley   +1 more source

Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension. [PDF]

Front Med (Lausanne)
Li Y, Zhu B, Shi K, Lu Y, Zeng X, Li Y, Zhang Q, Feng Y, Wang X.   +8 more
europepmc   +1 more source

Causalgenesis of liver fibrosis accompanied with portal hypertension.

, 1976
Toshio Shikata, T Uzawa, Shigeyuki Yamazaki   +2 more
openalex   +2 more sources

Hyperuricaemia in type 1 Gaucher disease: is uric acid a biomarker for disease severity?

Internal Medicine Journal, EarlyView.
Abstract Background Elevated serum uric acid (SUA) levels were observed in Gaucher disease type 1 (GD1) patients followed for two decades in northern Israel. There are no previous reports regarding hyperuricaemia in GD1 patients. Aims We aimed to evaluate the frequency of hyperuricaemia in GD1 patients and its correlation to disease severity ...
Zufit Hexner‐Erlichman, Salmas Watad, Jeff Szer, Nayaf Habashi, Hanna Rosenbaum   +4 more
wiley   +1 more source

Non-invasive assessment of portal hypertension: Liver stiffness and beyond. [PDF]

JHEP Rep
Mandorfer M, Abraldes JG, Berzigotti A.
europepmc   +1 more source

Addressing Food Affordability in Italy: An Analysis of Food Inflation Dynamics Using Open Data

International Social Science Journal, EarlyView.
ABSTRACT The COVID‐19 pandemic and the Russia‐Ukraine conflict have worsened global food insecurity and deepened inequalities. Disruptions in food supply chains have led to rising prices and food insecurity worldwide. In Italy and other European countries, high inflation rates have underscored the need for real‐time data to inform economic research and
Ilaria Benedetti
wiley   +1 more source

A novel noninvasive assessment of portal pressure from computational biofluid mechanics in patients with portal hypertension. [PDF]

Trials
Zheng L, Wu G, Lin J, Li H, Zhang C, Zhao Z, Chen M, Wu Z, Luo G, Fan Q, Qi X, Huo H, Sun L, Luo M.   +13 more
europepmc   +1 more source

Localization of vascular resistance and significance of hepatic artery playing for development of portal hypertension in the choline deficient diet induced rat liver cirrhosis.

, 1975
Yuro Shibayama
openalex   +2 more sources